CoChat

Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease

Open access
ter Horst, Kasper W., Vatner, Daniel F., Zhang, Dongyan, Cline, Gary W., Ackermans, Mariette T., Nederveen, Aart J., Verheij, Joanne, Demirkiran, Ahmet, van Wagensveld, Bart A., Dallinga-Thie, Geesje M., Nieuwdorp, Max, Romijn, Johannes A., Shulman, Gerald I., Serlie, Mireille J. · 2021 · Diabetes Care

The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Both glucose and triglyceride production are increased in type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). For decades, the leading hypothesis to explain these paradoxical observations has been selective hepatic insulin resistance wherein insulin drives de novo lipogenesis (DNL) while failing to suppress glucose production. Here, we aimed to test this hypothesis in humans. RESEARCH DESIGN AND METHODS: We recruited obese subjects who met criteria for bariatric surgery with (n = 16) or without (n = 15) NAFLD and assessed 1) insulin-mediated regulation of hepatic and peripheral glucose metabolism using hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose, 2) fasting and carbohydrate-driven hepatic DNL using deuterated water (2H2O), and 3) hepatocellular insulin signaling in liver biopsy samples collected during bariatric surgery. RESULTS: Compared with subjects without NAFLD, those with NAFLD demonstrated impaired insulin-mediated suppression of glucose production and attenuated—not increased—glucose-stimulated/high-insulin lipogenesis. Fructose-stimulated/low-insulin lipogenesis was intact. Hepatocellular insulin signaling, assessed for the first time in humans, exhibited a proximal block in insulin-resistant subjects: Signaling was attenuated from the level of the insulin receptor through both glucose and lipogenesis pathways. The carbohydrate-regulated lipogenic transcription factor ChREBP was increased in subjects with NAFLD. CONCLUSIONS: Acute increases in lipogenesis in humans with NAFLD are not explained by altered molecular regulation of lipogenesis through a paradoxical increase in lipogenic insulin action; rather, increases in lipogenic substrate availability may be the key.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc20-1644

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 1

  1. Jones, 1996, Tracing lipogenesis in humans using deuterated water, Can J Physiol Pharmacol, 74, 755, 10.1139/y96-070 · doi:10.1139/y96-070 · Paper page

Cited by

See all 89

Metadata

Authors
ter Horst, K. W., Vatner, D. F., Zhang, D., Cline, G. W., Ackermans, M. T., Nederveen, A. J., Verheij, J., Demirkiran, A., van Wagensveld, B. A., Dallinga-Thie, G. M., Nieuwdorp, M., Romijn, J. A., Shulman, G. I., & Serlie, M. J.
Affiliations
  • Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, the Netherlands
  • Yale University (US)
  • Department of Clinical Chemistry, Laboratory of Endocrinology, Amsterdam University Medical Center, Amsterdam, the Netherlands
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Department of Surgery, Red Cross Hospital, Beverwijk, the Netherlands
  • Department of Surgery, OLVG West, Amsterdam, the Netherlands
  • Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands
  • Amsterdam University Medical Centers (NL)
Corresponding author
Serlie, Mireille J.
Venue
Diabetes Care
Published
2020-12-08
Volume
44
Issue
2
Pages
489-498
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W3110973280
Cited by
88
References
54
Citations by year
2026: 15 · 2025: 11 · 2024: 20 · 2023: 17 · 2022: 9 · 2021: 16
FWCI
7.52
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (acceptedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
Funders
  • European Commission (FP7-EU 305707)
  • National Institutes of Health (R01-DK-124272, K23-DK-10287)
  • ZonMw (VIDI 016.146.327)
  • Hartstichting (CVON IN-CONTROL, R01-DK-113984, R01-DK-119968, P30-DK-45735)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
non-alcoholic fatty liver disease, hepatic insulin resistance, de novo lipogenesis, hepatic glucose production, insulin signaling, insulin receptor, ChREBP, fructose, hyperinsulinemic-euglycemic clamp, bariatric surgery, obesity
MeSH terms
Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Liver, Lipogenesis, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.